Guizhou Fukangren Pharmaceutical Co., Ltd.
The industrial base of Guizhou Fukangren Pharmaceutical Co., Ltd. is located in the Yunjin Medical and Food New Industrial Park, Luowan, Wudang District, Guiyang City. The total land area of the project is about 182.6 mu. The construction is divided into two phases, the first phase is an anti-tumor drug production base, and the second phase is a comprehensive chemical drug production base.
In accordance with the requirements of FDA, EU EMEA, China 2010 version of GMP, the anti-tumor workshop adopts internationally advanced Isolator man-machine isolation technology and robot automatic production line, SCADA system, which can realize real-time monitoring and control, data acquisition, and human-machine interaction. Humanized production.
Two production lines have been built for freeze-dried powder injection and non-terminal sterilized water injection.
Designed production scale: 12 million bottles of small-capacity injections per year, 3.85 million bottles of freeze-dried powder injections per year. It is estimated that the annual output value can reach 300-500 million yuan in 3-5 years.
API Center
The industrial base of Guizhou Fukangren Pharmaceutical Co., Ltd. is located in the Yunjin Medical and Food New Industrial Park, Luowan, Wudang District, Guiyang City. The total land area of the project is about 182.6 mu. The construction is divided into two phases, the first phase is an anti-tumor drug production base, and the second phase is a comprehensive chemical drug production base.
In accordance with the requirements of FDA, EU EMEA, China 2010 version of GMP, the anti-tumor workshop adopts internationally advanced Isolator man-machine isolation technology and robot automatic production line, SCADA system, which can realize real-time monitoring and control, data acquisition, and human-machine interaction. Humanized production.
